|
1
|
Raman JD, Sosa RE, Vaughan ED Jr and
Scherr DS: Pathologic features of bladder tumors after
nephroureterectomy or segmental ureterectomy for upper urinary
tract transitional cell carcinoma. Urology. 69:251–254. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clark PE, Agarwal N, Biagioli MC, et al:
National Comprehensive Cancer Network (NCCN): Bladder cancer. J
Natl Compr Canc Netw. 11:446–475. 2013.PubMed/NCBI
|
|
3
|
Rouprêt M, Babjuk M, Compérat E, et al:
European Association of Urology: European guidelines on upper tract
urothelial carcinomas: 2013 update. Eur Urol. 63:1059–1071. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leow JJ, Martin-Doyle W, Fay AP, Choueiri
TK, Chang SL and Bellmunt J: A systematic review and meta-analysis
of adjuvant and neoadjuvant chemotherapy for upper tract urothelial
carcinoma. Eur Urol. 66:529–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Porten S, Siefker-Radtke AO, Xiao L,
Margulis V, Kamat AM, Wood CG, Jonasch E, Dinney CP and Matin SF:
Neoadjuvant chemotherapy improves survival of patients with upper
tract urothelial carcinoma. Cancer. 120:1794–1799. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo YZ, Pan L, Du CJ, Ren DQ and Xie XM:
Association between C-reactive protein and risk of cancer: A
meta-analysis of prospective cohort studies. Asian Pac J Cancer
Prev. 14:243–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu Q, Gou Y, Sun C, et al: The prognostic
value of C reactive protein in renal cell carcinoma: A systematic
review and meta-analysis. Urol Oncol. 32:50.e1–e8. 2014. View Article : Google Scholar
|
|
8
|
Wells GA, Shea B, O'Connell D, et al: The
Newcastle Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed.
December 20–2014
|
|
9
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8:162007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Higgins JPT and Green S: Cochrane Handbook
for Systematic Reviews of Interventions. Version 5.1.0. updated.
March;2011.http://handbook.cochrane.org/Accessed. December
20–2014
|
|
12
|
Ioannidis JP and Trikalinos TA: The
appropriateness of asymmetry tests for publication bias in
meta-analyses: A large survey. CMAJ. 176:1091–1096. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aziz A, Rink M, Gakis G, et al:
Preoperative C-reactive protein in the serum: A prognostic
biomarker for upper urinary tract urothelial carcinoma treated with
radical nephroureterectomy. Urol Int. 93:352–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Azuma T, Matayoshi Y, Odani K, Sato Y,
Sato Y, Nagase Y and Oshi M: Preoperative neutrophil-lymphocyte
ratio as an independent prognostic marker for patients with upper
urinary tract urothelial carcinoma. Clin Genitourin Cancer.
11:337–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cho YH, Seo YH, Chung SJ, et al:
Predictors of intravesical recurrence after radical
nephroureterectomy for upper urinary tract urothelial carcinoma: An
inflammation-based prognostic score. Korean J Urol. 55:453–459.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saito K, Kawakami S, Ohtsuka Y, Fujii Y,
Masuda H, Kumagai J, Kobayashi T, Kageyama Y and Kihara K: The
impact of preoperative serum C-reactive protein on the prognosis of
patients with upper urinary tract urothelial carcinoma treated
surgically. BJU Int. 100:269–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sakano S, Matsuyama H, Kamiryo Y, et al:
Yamaguchi Uro-Oncology Group: Risk group stratification based on
preoperative factors to predict survival after nephroureterectomy
in patients with upper urinary tract urothelial carcinoma. Ann Surg
Oncol. 20:4389–4396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stein B, Schrader AJ, Wegener G, Seidel C,
Kuczyk MA and Steffens S: Preoperative serum C-reactive protein: A
prognostic marker in patients with upper urinary tract urothelial
carcinoma. BMC Cancer. 13:1012013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanaka N, Kikuchi E, Shirotake S, et al:
The predictive value of C-reactive protein for prognosis in
patients with upper tract urothelial carcinoma treated with radical
nephroureterectomy: A multi-institutional study. Eur Urol.
65:227–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin Y, Sun Y, Shi X, Zhao J, Shi L and Yu
X: Prognostic value of circulating C-reactive protein levels in
patients with non-small cell lung cancer: A systematic review with
meta-analysis. J Cancer Res Ther. 10:(Suppl). C160–C166. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu ZQ, Chu L, Fang JM, Zhang X, Zhao HX,
Chen YJ and Xu Q: Prognostic role of C-reactive protein in prostate
cancer: A systematic review and meta-analysis. Asian J Androl.
16:467–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh PP, Zeng ISL, Srinivasa S, Lemanu
DP, Connolly AB and Hill AG: Systematic review and meta-analysis of
use of serum C-reactive protein levels to predict anastomotic leak
after colorectal surgery. Br J Surg. 101:339–346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Warschkow R, Tarantino I, Ukegjini K,
Beutner U, Müller SA, Schmied BM and Steffen T: Diagnostic study
and meta-analysis of C-reactive protein as a predictor of
postoperative inflammatory complications after gastroesophageal
cancer surgery. Langenbecks Arch Surg. 397:727–736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yi JH, Wang D, Li ZY, Hu J, Niu XF and Liu
XL: C-reactive protein as a prognostic factor for human
osteosarcoma: A meta-analysis and literature review. PLoS One.
9:e946322014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu Q, Yu XF, Zhang SD, Wang HH, Wang HY
and Teng LS: Prognostic role of C-reactive protein in gastric
cancer: A meta-analysis. Asian Pac J Cancer Prev. 14:5735–5740.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng Z, Zhou L, Gao S, Yang Z, Yao J and
Zheng S: Prognostic role of C-reactive protein in hepatocellular
carcinoma: A systematic review and meta-analysis. Int J Med Sci.
10:653–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lughezzani G, Burger M, Margulis V, Matin
SF, Novara G, Roupret M, Shariat SF, Wood CG and Zigeuner R:
Prognostic factors in upper urinary tract urothelial carcinomas: A
comprehensive review of the current literature. Eur Urol.
62:100–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishikawa S, Abe T, Shinohara N, et al:
Impact of diagnostic ureteroscopy on intravesical recurrence and
survival in patients with urothelial carcinoma of the upper urinary
tract. J Urol. 184:883–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo HL, Kang CH, Chen YT, Chuang YC, Lee
WC, Cheng YT and Chiang PH: Diagnostic ureteroscopy independently
correlates with intravesical recurrence after nephroureterectomy
for upper urinary tract urothelial carcinoma. Ann Surg Oncol.
20:3121–3126. 2013. View Article : Google Scholar : PubMed/NCBI
|
